The prescription of best medical therapy following infrainguinal bypass grafting in Australia and New Zealand: a multicentre Australasian audit.

Sam FarahRicky KwokAnastasia DeanYogeesan SivakumaranSamantha KhooMaximilian JoretShirley J Jansen Sarah Joy Aitkennull null

Published in: ANZ journal of surgery (2021)

Almost one third of patients were not prescribed complete BMT following IIB. There is potential to improve the outcomes after IIB in ANZ through a focus on risk-factor control and BMT prescription.

Keyphrases

end stage renal disease
newly diagnosed
risk factors
chronic kidney disease
ejection fraction
healthcare
prognostic factors
peritoneal dialysis
patient reported outcomes
risk assessment
patient reported
cell therapy
replacement therapy